ANTICOAGULANTI RIDUCONO LA MORTALITA PER COVID-19 OSPEDALIZZATI A DOSI PROFILATTICHE: LE DOSI TERAPEUTICHE AUMENTANO INVECE IL RISCHIO DI DECESSO. UNA META-ANALISI SU OLTRE 35.000 PAZIENTI
Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis Chatphatai Moonla, et al. Abstract Hypercoagulability in coronavirus disease 2019 (COVID-19) may aggravate disease severity during hospitalization but the reported survival benefits from anticoagulation (AC) vary among studies. We performed a literature research to estimate pooled odds ratios (ORs) of in-hospital mortality…

